EDMONTON, Alberta, Sept. 5 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pink Sheets: MSITF) wishes to announce that projections based on current orders and requirements from distributors indicate that it will produce 1.24 million test kits in the second quarter for delivery in the third quarter of the fiscal year. The majority of the kits to be delivered are HIV test kits. The Company will also deliver VScan TB, Malaria, Hepatitis C and Dengue Fever kits in larger numbers than originally projected.
The company continues to work as fast as possible on all filings. The website is currently being updated and is anticipated to be ready by the end of September, 2007. The Company continues to get requests from regulatory agencies worldwide that wish to test our VScan products. The company will supply up to 10,000 test kits for testing with various regulatory agencies in the next 3 months. The test results that are received are used to obtain additional approvals in new areas.
Medical Services International Inc. trades in the United States on the NQB Pink Sheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com or http://www.minerva-biotech.com.
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially.
Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies
|SOURCE Medical Services International Inc.|
Copyright©2007 PR Newswire.
All rights reserved